nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CBR1—Doxorubicin—liver cancer	0.819	0.907	CbGbCtD
Tetrabenazine—CYP2D6—Sorafenib—liver cancer	0.052	0.0576	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—liver cancer	0.0315	0.035	CbGbCtD
Tetrabenazine—CBR1—Arachidonic acid metabolism—HPGDS—liver cancer	0.00255	0.0407	CbGpPWpGaD
Tetrabenazine—CBR1—Arachidonic acid metabolism—GGT1—liver cancer	0.00191	0.0304	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GSTA3—liver cancer	0.00159	0.0254	CbGpPWpGaD
Tetrabenazine—CBR1—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00149	0.0238	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GSTA4—liver cancer	0.00145	0.0232	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GSTA2—liver cancer	0.00142	0.0226	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GSTA1—liver cancer	0.00137	0.0218	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00121	0.0193	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—NFE2L2—liver cancer	0.0012	0.0192	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00115	0.0184	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—TGFA—liver cancer	0.00115	0.0183	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GPX3—liver cancer	0.00115	0.0183	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—SERPINA1—liver cancer	0.00113	0.0181	CbGpPWpGaD
Tetrabenazine—CYP2D6—CYP2E1 reactions—CYP2E1—liver cancer	0.000906	0.0145	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000876	0.014	CbGpPWpGaD
Tetrabenazine—Abdominal pain upper—Sorafenib—liver cancer	0.000839	0.0239	CcSEcCtD
Tetrabenazine—Hypothermia—Epirubicin—liver cancer	0.000834	0.0238	CcSEcCtD
Tetrabenazine—Body temperature decreased—Epirubicin—liver cancer	0.000834	0.0238	CcSEcCtD
Tetrabenazine—Breast disorder—Sorafenib—liver cancer	0.00083	0.0236	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—GGT1—liver cancer	0.000808	0.0129	CbGpPWpGaD
Tetrabenazine—Dysphagia—Sorafenib—liver cancer	0.000794	0.0226	CcSEcCtD
Tetrabenazine—Body temperature decreased—Doxorubicin—liver cancer	0.000772	0.022	CcSEcCtD
Tetrabenazine—Hypothermia—Doxorubicin—liver cancer	0.000772	0.022	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—GSTP1—liver cancer	0.000726	0.0116	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—HMOX1—liver cancer	0.000716	0.0114	CbGpPWpGaD
Tetrabenazine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.000671	0.0107	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GSTM1—liver cancer	0.000667	0.0107	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—HGF—liver cancer	0.000667	0.0107	CbGpPWpGaD
Tetrabenazine—Urinary tract disorder—Sorafenib—liver cancer	0.000627	0.0179	CcSEcCtD
Tetrabenazine—Urethral disorder—Sorafenib—liver cancer	0.000623	0.0177	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—GLUL—liver cancer	0.000607	0.00969	CbGpPWpGaD
Tetrabenazine—Cardiac disorder—Sorafenib—liver cancer	0.000589	0.0168	CcSEcCtD
Tetrabenazine—Angiopathy—Sorafenib—liver cancer	0.000576	0.0164	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000565	0.00902	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—SIX3—liver cancer	0.000562	0.00897	CbGpPWpGaD
Tetrabenazine—CYP2D6—Xenobiotics—CYP2E1—liver cancer	0.000562	0.00897	CbGpPWpGaD
Tetrabenazine—DRD2—Hypothetical Network for Drug Addiction—PRKCE—liver cancer	0.00056	0.00894	CbGpPWpGaD
Tetrabenazine—Blood disorder—Epirubicin—liver cancer	0.00056	0.0159	CcSEcCtD
Tetrabenazine—Mental disorder—Sorafenib—liver cancer	0.000556	0.0159	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000548	0.00876	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000544	0.00869	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000544	0.00869	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000544	0.00869	CbGpPWpGaD
Tetrabenazine—CYP2D6—Tamoxifen metabolism—CYP2E1—liver cancer	0.00054	0.00862	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000523	0.00835	CbGpPWpGaD
Tetrabenazine—Blood disorder—Doxorubicin—liver cancer	0.000518	0.0148	CcSEcCtD
Tetrabenazine—Leukopenia—Sorafenib—liver cancer	0.000495	0.0141	CcSEcCtD
Tetrabenazine—Dysarthria—Epirubicin—liver cancer	0.000494	0.0141	CcSEcCtD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—STAT3—liver cancer	0.000485	0.00774	CbGpPWpGaD
Tetrabenazine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000482	0.0077	CbGpPWpGaD
Tetrabenazine—Gait disturbance—Epirubicin—liver cancer	0.000479	0.0136	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000467	0.0133	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—GLUL—liver cancer	0.000465	0.00742	CbGpPWpGaD
Tetrabenazine—Dry mouth—Sorafenib—liver cancer	0.00046	0.0131	CcSEcCtD
Tetrabenazine—Dysarthria—Doxorubicin—liver cancer	0.000457	0.013	CcSEcCtD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—liver cancer	0.000449	0.00717	CbGpPWpGaD
Tetrabenazine—Gait disturbance—Doxorubicin—liver cancer	0.000443	0.0126	CcSEcCtD
Tetrabenazine—Nervous system disorder—Sorafenib—liver cancer	0.000443	0.0126	CcSEcCtD
Tetrabenazine—Skin disorder—Sorafenib—liver cancer	0.000438	0.0125	CcSEcCtD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000428	0.00684	CbGpPWpGaD
Tetrabenazine—Ecchymosis—Epirubicin—liver cancer	0.000423	0.012	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000416	0.00665	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—UGDH—liver cancer	0.000415	0.00663	CbGpPWpGaD
Tetrabenazine—CYP2D6—Xenobiotics—CYP1A1—liver cancer	0.000403	0.00644	CbGpPWpGaD
Tetrabenazine—Dyspnoea—Sorafenib—liver cancer	0.000402	0.0115	CcSEcCtD
Tetrabenazine—Decreased appetite—Sorafenib—liver cancer	0.000392	0.0112	CcSEcCtD
Tetrabenazine—Ecchymosis—Doxorubicin—liver cancer	0.000391	0.0111	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—EPT1—liver cancer	0.00039	0.00623	CbGpPWpGaD
Tetrabenazine—Fatigue—Sorafenib—liver cancer	0.000389	0.0111	CcSEcCtD
Tetrabenazine—CYP2D6—Tamoxifen metabolism—CYP1A1—liver cancer	0.000388	0.0062	CbGpPWpGaD
Tetrabenazine—Constipation—Sorafenib—liver cancer	0.000386	0.011	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—TAT—liver cancer	0.00037	0.00591	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000364	0.00581	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Sorafenib—liver cancer	0.000357	0.0102	CcSEcCtD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000347	0.00554	CbGpPWpGaD
Tetrabenazine—Osteoarthritis—Epirubicin—liver cancer	0.000339	0.00967	CcSEcCtD
Tetrabenazine—Asthenia—Sorafenib—liver cancer	0.000324	0.00922	CcSEcCtD
Tetrabenazine—Ataxia—Epirubicin—liver cancer	0.000319	0.00909	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—UGDH—liver cancer	0.000316	0.00504	CbGpPWpGaD
Tetrabenazine—Osteoarthritis—Doxorubicin—liver cancer	0.000314	0.00894	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Epirubicin—liver cancer	0.00031	0.00883	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Epirubicin—liver cancer	0.00031	0.00883	CcSEcCtD
Tetrabenazine—Diarrhoea—Sorafenib—liver cancer	0.000309	0.0088	CcSEcCtD
Tetrabenazine—Breast disorder—Epirubicin—liver cancer	0.000307	0.00873	CcSEcCtD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—CYP1A1—liver cancer	0.0003	0.00479	CbGpPWpGaD
Tetrabenazine—Dizziness—Sorafenib—liver cancer	0.000298	0.0085	CcSEcCtD
Tetrabenazine—Ataxia—Doxorubicin—liver cancer	0.000295	0.00841	CcSEcCtD
Tetrabenazine—Dysphagia—Epirubicin—liver cancer	0.000293	0.00835	CcSEcCtD
Tetrabenazine—Vomiting—Sorafenib—liver cancer	0.000287	0.00817	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Doxorubicin—liver cancer	0.000287	0.00817	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000287	0.00817	CcSEcCtD
Tetrabenazine—Breast disorder—Doxorubicin—liver cancer	0.000284	0.00808	CcSEcCtD
Tetrabenazine—Headache—Sorafenib—liver cancer	0.000283	0.00805	CcSEcCtD
Tetrabenazine—Bronchitis—Epirubicin—liver cancer	0.000282	0.00803	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000279	0.00445	CbGpPWpGaD
Tetrabenazine—Dysuria—Epirubicin—liver cancer	0.000274	0.00781	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000273	0.00776	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000272	0.00435	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—TGFB1—liver cancer	0.000272	0.00434	CbGpPWpGaD
Tetrabenazine—Dysphagia—Doxorubicin—liver cancer	0.000271	0.00773	CcSEcCtD
Tetrabenazine—Nausea—Sorafenib—liver cancer	0.000268	0.00764	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000266	0.00425	CbGpPWpGaD
Tetrabenazine—Drowsiness—Epirubicin—liver cancer	0.000261	0.00745	CcSEcCtD
Tetrabenazine—Bronchitis—Doxorubicin—liver cancer	0.000261	0.00743	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000255	0.00407	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000255	0.00407	CbGpPWpGaD
Tetrabenazine—Dysuria—Doxorubicin—liver cancer	0.000254	0.00723	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000252	0.00718	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GLUL—liver cancer	0.000251	0.00402	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CPT1B—liver cancer	0.000251	0.00402	CbGpPWpGaD
Tetrabenazine—Sweating—Epirubicin—liver cancer	0.000251	0.00714	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—NR1H4—liver cancer	0.000242	0.00387	CbGpPWpGaD
Tetrabenazine—Drowsiness—Doxorubicin—liver cancer	0.000242	0.00689	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000241	0.00385	CbGpPWpGaD
Tetrabenazine—Bradycardia—Epirubicin—liver cancer	0.000239	0.00681	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTA3—liver cancer	0.000238	0.00381	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000233	0.00372	CbGpPWpGaD
Tetrabenazine—Sweating—Doxorubicin—liver cancer	0.000232	0.00661	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Epirubicin—liver cancer	0.000232	0.0066	CcSEcCtD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00023	0.00367	CbGpPWpGaD
Tetrabenazine—Urethral disorder—Epirubicin—liver cancer	0.00023	0.00655	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—liver cancer	0.000221	0.0063	CcSEcCtD
Tetrabenazine—Eye disorder—Epirubicin—liver cancer	0.000219	0.00625	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTA4—liver cancer	0.000218	0.00348	CbGpPWpGaD
Tetrabenazine—Cardiac disorder—Epirubicin—liver cancer	0.000218	0.00621	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Doxorubicin—liver cancer	0.000214	0.00611	CcSEcCtD
Tetrabenazine—DRD2—Circadian rythm related genes—AHR—liver cancer	0.000213	0.00341	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000213	0.0034	CbGpPWpGaD
Tetrabenazine—Angiopathy—Epirubicin—liver cancer	0.000213	0.00607	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—liver cancer	0.000213	0.00606	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTA2—liver cancer	0.000212	0.00339	CbGpPWpGaD
Tetrabenazine—Mental disorder—Epirubicin—liver cancer	0.000206	0.00586	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTA1—liver cancer	0.000205	0.00327	CbGpPWpGaD
Tetrabenazine—Eye disorder—Doxorubicin—liver cancer	0.000203	0.00578	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—NAT2—liver cancer	0.000203	0.00324	CbGpPWpGaD
Tetrabenazine—Cardiac disorder—Doxorubicin—liver cancer	0.000202	0.00574	CcSEcCtD
Tetrabenazine—Tension—Epirubicin—liver cancer	0.000201	0.00571	CcSEcCtD
Tetrabenazine—Nervousness—Epirubicin—liver cancer	0.000198	0.00565	CcSEcCtD
Tetrabenazine—DRD2—G alpha (i) signalling events—CCR4—liver cancer	0.000197	0.00315	CbGpPWpGaD
Tetrabenazine—Angiopathy—Doxorubicin—liver cancer	0.000197	0.00561	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000195	0.00311	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ALDOB—liver cancer	0.000194	0.0031	CbGpPWpGaD
Tetrabenazine—Mental disorder—Doxorubicin—liver cancer	0.00019	0.00542	CcSEcCtD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000189	0.00302	CbGpPWpGaD
Tetrabenazine—Agitation—Epirubicin—liver cancer	0.000188	0.00535	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—liver cancer	0.000186	0.00529	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—CRABP1—liver cancer	0.000185	0.00296	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—NR1H4—liver cancer	0.000184	0.00294	CbGpPWpGaD
Tetrabenazine—Nervousness—Doxorubicin—liver cancer	0.000184	0.00523	CcSEcCtD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.000183	0.00292	CbGpPWpGaD
Tetrabenazine—Leukopenia—Epirubicin—liver cancer	0.000183	0.00521	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—GSTA3—liver cancer	0.000181	0.00289	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTA3—liver cancer	0.000179	0.00285	CbGpPWpGaD
Tetrabenazine—Agitation—Doxorubicin—liver cancer	0.000174	0.00495	CcSEcCtD
Tetrabenazine—Anxiety—Epirubicin—liver cancer	0.000173	0.00494	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000173	0.00492	CcSEcCtD
Tetrabenazine—Dry mouth—Epirubicin—liver cancer	0.00017	0.00485	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—liver cancer	0.000169	0.00482	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—BRAF—liver cancer	0.000169	0.00269	CbGpPWpGaD
Tetrabenazine—Confusional state—Epirubicin—liver cancer	0.000168	0.00479	CcSEcCtD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000168	0.00268	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000167	0.00267	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTA4—liver cancer	0.000166	0.00265	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000165	0.00264	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Epirubicin—liver cancer	0.000164	0.00466	CcSEcCtD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTA4—liver cancer	0.000163	0.00261	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—HPGDS—liver cancer	0.000162	0.00259	CbGpPWpGaD
Tetrabenazine—Skin disorder—Epirubicin—liver cancer	0.000162	0.00461	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—GSTA2—liver cancer	0.000162	0.00258	CbGpPWpGaD
Tetrabenazine—Hyperhidrosis—Epirubicin—liver cancer	0.000161	0.00459	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000161	0.00257	CbGpPWpGaD
Tetrabenazine—Anxiety—Doxorubicin—liver cancer	0.00016	0.00457	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00016	0.00455	CcSEcCtD
Tetrabenazine—Dry mouth—Doxorubicin—liver cancer	0.000157	0.00448	CcSEcCtD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.000157	0.0025	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTA1—liver cancer	0.000156	0.00249	CbGpPWpGaD
Tetrabenazine—Hypotension—Epirubicin—liver cancer	0.000156	0.00444	CcSEcCtD
Tetrabenazine—Confusional state—Doxorubicin—liver cancer	0.000156	0.00443	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—NAT2—liver cancer	0.000154	0.00246	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000152	0.00243	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Doxorubicin—liver cancer	0.000151	0.00431	CcSEcCtD
Tetrabenazine—Insomnia—Epirubicin—liver cancer	0.000151	0.0043	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—liver cancer	0.00015	0.00427	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Doxorubicin—liver cancer	0.000149	0.00425	CcSEcCtD
Tetrabenazine—Dyspnoea—Epirubicin—liver cancer	0.000149	0.00424	CcSEcCtD
Tetrabenazine—Somnolence—Epirubicin—liver cancer	0.000148	0.00422	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000147	0.00234	CbGpPWpGaD
Tetrabenazine—Decreased appetite—Epirubicin—liver cancer	0.000145	0.00413	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000145	0.00231	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PSMD10—liver cancer	0.000144	0.00231	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PSMA4—liver cancer	0.000144	0.00231	CbGpPWpGaD
Tetrabenazine—Hypotension—Doxorubicin—liver cancer	0.000144	0.00411	CcSEcCtD
Tetrabenazine—Fatigue—Epirubicin—liver cancer	0.000144	0.0041	CcSEcCtD
Tetrabenazine—Constipation—Epirubicin—liver cancer	0.000143	0.00406	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000141	0.00225	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GOT2—liver cancer	0.00014	0.00224	CbGpPWpGaD
Tetrabenazine—Insomnia—Doxorubicin—liver cancer	0.00014	0.00398	CcSEcCtD
Tetrabenazine—Dyspnoea—Doxorubicin—liver cancer	0.000138	0.00392	CcSEcCtD
Tetrabenazine—Feeling abnormal—Epirubicin—liver cancer	0.000137	0.00391	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—liver cancer	0.000137	0.00391	CcSEcCtD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000136	0.00217	CbGpPWpGaD
Tetrabenazine—Decreased appetite—Doxorubicin—liver cancer	0.000134	0.00382	CcSEcCtD
Tetrabenazine—Fatigue—Doxorubicin—liver cancer	0.000133	0.00379	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—CYP2E1—liver cancer	0.000132	0.00211	CbGpPWpGaD
Tetrabenazine—Constipation—Doxorubicin—liver cancer	0.000132	0.00376	CcSEcCtD
Tetrabenazine—Body temperature increased—Epirubicin—liver cancer	0.000132	0.00376	CcSEcCtD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000129	0.00206	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—BRAF—liver cancer	0.000129	0.00206	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000128	0.00204	CbGpPWpGaD
Tetrabenazine—Feeling abnormal—Doxorubicin—liver cancer	0.000127	0.00362	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000126	0.00202	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYCS—liver cancer	0.000124	0.00197	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000123	0.00197	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000123	0.00196	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Doxorubicin—liver cancer	0.000122	0.00347	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GOT1—liver cancer	0.000121	0.00194	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GGT1—liver cancer	0.000121	0.00194	CbGpPWpGaD
Tetrabenazine—Asthenia—Epirubicin—liver cancer	0.00012	0.00341	CcSEcCtD
Tetrabenazine—DRD2—GPCR ligand binding—CCR4—liver cancer	0.000119	0.00191	CbGpPWpGaD
Tetrabenazine—Diarrhoea—Epirubicin—liver cancer	0.000114	0.00325	CcSEcCtD
Tetrabenazine—Asthenia—Doxorubicin—liver cancer	0.000111	0.00315	CcSEcCtD
Tetrabenazine—Dizziness—Epirubicin—liver cancer	0.00011	0.00314	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTP1—liver cancer	0.000109	0.00174	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—RAF1—liver cancer	0.000108	0.00172	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—HMOX1—liver cancer	0.000107	0.00172	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000107	0.00171	CbGpPWpGaD
Tetrabenazine—Vomiting—Epirubicin—liver cancer	0.000106	0.00302	CcSEcCtD
Tetrabenazine—Diarrhoea—Doxorubicin—liver cancer	0.000106	0.00301	CcSEcCtD
Tetrabenazine—Headache—Epirubicin—liver cancer	0.000104	0.00298	CcSEcCtD
Tetrabenazine—Dizziness—Doxorubicin—liver cancer	0.000102	0.00291	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.0001	0.0016	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTM1—liver cancer	0.0001	0.0016	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PPARA—liver cancer	9.99e-05	0.00159	CbGpPWpGaD
Tetrabenazine—Nausea—Epirubicin—liver cancer	9.91e-05	0.00282	CcSEcCtD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	9.9e-05	0.00158	CbGpPWpGaD
Tetrabenazine—Vomiting—Doxorubicin—liver cancer	9.81e-05	0.00279	CcSEcCtD
Tetrabenazine—Headache—Doxorubicin—liver cancer	9.67e-05	0.00275	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—CYP1A1—liver cancer	9.49e-05	0.00152	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GGT1—liver cancer	9.22e-05	0.00147	CbGpPWpGaD
Tetrabenazine—Nausea—Doxorubicin—liver cancer	9.17e-05	0.00261	CcSEcCtD
Tetrabenazine—DRD2—Signaling Pathways—CHN2—liver cancer	9.1e-05	0.00145	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—MTHFR—liver cancer	8.85e-05	0.00141	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PPARA—liver cancer	8.68e-05	0.00139	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—PPARA—liver cancer	8.63e-05	0.00138	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IFT88—liver cancer	8.32e-05	0.00133	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTP1—liver cancer	8.28e-05	0.00132	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PPARG—liver cancer	8.25e-05	0.00132	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	8.17e-05	0.0013	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.8e-05	0.00124	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—HRAS—liver cancer	7.75e-05	0.00124	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTM1—liver cancer	7.61e-05	0.00122	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	7.51e-05	0.0012	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—SERPINE1—liver cancer	7.44e-05	0.00119	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CG—liver cancer	7.43e-05	0.00119	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	7.21e-05	0.00115	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PPARG—liver cancer	7.17e-05	0.00115	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	7.12e-05	0.00114	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—TRIO—liver cancer	7.04e-05	0.00112	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CCR4—liver cancer	6.75e-05	0.00108	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CD—liver cancer	6.53e-05	0.00104	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ALB—liver cancer	6.45e-05	0.00103	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ALB—liver cancer	6.41e-05	0.00102	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—TRIO—liver cancer	6.39e-05	0.00102	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	6.27e-05	0.001	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCR4—liver cancer	6.13e-05	0.000979	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—HRAS—liver cancer	5.94e-05	0.000948	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—JUN—liver cancer	5.85e-05	0.000935	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—RAF1—liver cancer	5.8e-05	0.000926	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CB—liver cancer	5.7e-05	0.000909	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—MAPK8—liver cancer	5.54e-05	0.000885	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UGDH—liver cancer	5.4e-05	0.000862	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SHC3—liver cancer	5.1e-05	0.000814	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—EPT1—liver cancer	5.07e-05	0.00081	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TAT—liver cancer	4.81e-05	0.000768	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—F2—liver cancer	4.77e-05	0.000762	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FST—liver cancer	3.96e-05	0.000632	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PRKCE—liver cancer	3.89e-05	0.000621	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—liver cancer	3.86e-05	0.000617	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TRIO—liver cancer	3.78e-05	0.000603	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCR4—liver cancer	3.62e-05	0.000578	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—IL6—liver cancer	3.54e-05	0.000565	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PRKCE—liver cancer	3.53e-05	0.000564	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CA—liver cancer	3.47e-05	0.000554	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CSF2—liver cancer	3.44e-05	0.000549	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CPT1B—liver cancer	3.27e-05	0.000522	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GLUL—liver cancer	3.27e-05	0.000522	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NR1H4—liver cancer	3.15e-05	0.000503	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CSF2—liver cancer	3.12e-05	0.000499	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA3—liver cancer	3.1e-05	0.000495	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADAM17—liver cancer	2.86e-05	0.000457	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKT1—liver cancer	2.84e-05	0.000453	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA4—liver cancer	2.83e-05	0.000453	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA2—liver cancer	2.76e-05	0.000441	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—F2—liver cancer	2.7e-05	0.000431	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PSMA4—liver cancer	2.69e-05	0.00043	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PSMD10—liver cancer	2.69e-05	0.00043	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA1—liver cancer	2.67e-05	0.000426	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NAT2—liver cancer	2.64e-05	0.000421	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CG—liver cancer	2.58e-05	0.000412	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALDOB—liver cancer	2.53e-05	0.000403	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—F2—liver cancer	2.45e-05	0.000391	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CRABP1—liver cancer	2.41e-05	0.000385	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CG—liver cancer	2.35e-05	0.000374	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CD—liver cancer	2.27e-05	0.000362	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HPGDS—liver cancer	2.11e-05	0.000336	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRKCE—liver cancer	2.09e-05	0.000333	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CD—liver cancer	2.06e-05	0.000329	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CB—liver cancer	1.98e-05	0.000316	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF2—liver cancer	1.98e-05	0.000315	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PSMA4—liver cancer	1.88e-05	0.0003	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PSMD10—liver cancer	1.88e-05	0.0003	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CSF2—liver cancer	1.84e-05	0.000295	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—RAF1—liver cancer	1.84e-05	0.000294	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GOT2—liver cancer	1.83e-05	0.000292	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—H2AFX—liver cancer	1.82e-05	0.00029	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IL2—liver cancer	1.82e-05	0.00029	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CB—liver cancer	1.8e-05	0.000287	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2E1—liver cancer	1.72e-05	0.000274	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL2—liver cancer	1.65e-05	0.000264	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TERT—liver cancer	1.64e-05	0.000263	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYCS—liver cancer	1.61e-05	0.000257	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GOT1—liver cancer	1.58e-05	0.000252	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GGT1—liver cancer	1.58e-05	0.000252	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KDR—liver cancer	1.5e-05	0.00024	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK14—liver cancer	1.49e-05	0.000239	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ESR1—liver cancer	1.47e-05	0.000234	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—F2—liver cancer	1.45e-05	0.000231	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTP1—liver cancer	1.42e-05	0.000226	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HMOX1—liver cancer	1.4e-05	0.000223	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CG—liver cancer	1.39e-05	0.000221	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APC—liver cancer	1.39e-05	0.000221	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—BRAF—liver cancer	1.3e-05	0.000208	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—liver cancer	1.3e-05	0.000208	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.23e-05	0.000197	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CD—liver cancer	1.22e-05	0.000194	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	1.21e-05	0.000193	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SERPINE1—liver cancer	1.2e-05	0.000192	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—KRAS—liver cancer	1.19e-05	0.00019	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTHFR—liver cancer	1.15e-05	0.000184	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARA—liver cancer	1.13e-05	0.00018	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CA—liver cancer	1.1e-05	0.000175	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RAF1—liver cancer	1.09e-05	0.000174	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MTOR—liver cancer	1.06e-05	0.000169	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CB—liver cancer	1.06e-05	0.000169	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HRAS—liver cancer	1.01e-05	0.000162	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1B—liver cancer	9.96e-06	0.000159	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT1—liver cancer	9.85e-06	0.000157	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP3—liver cancer	9.76e-06	0.000156	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL2—liver cancer	9.75e-06	0.000156	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6—liver cancer	9.7e-06	0.000155	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CG—liver cancer	9.66e-06	0.000154	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCND1—liver cancer	9.5e-06	0.000152	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JUN—liver cancer	9.48e-06	0.000151	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CTNNB1—liver cancer	9.41e-06	0.00015	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARG—liver cancer	9.33e-06	0.000149	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP9—liver cancer	9.23e-06	0.000147	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1A—liver cancer	9.19e-06	0.000147	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK8—liver cancer	8.97e-06	0.000143	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT1—liver cancer	8.95e-06	0.000143	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CD—liver cancer	8.5e-06	0.000136	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALB—liver cancer	8.39e-06	0.000134	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—liver cancer	8.28e-06	0.000132	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT3—liver cancer	8.2e-06	0.000131	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MYC—liver cancer	7.62e-06	0.000122	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFB1—liver cancer	7.6e-06	0.000121	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CB—liver cancer	7.41e-06	0.000118	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KRAS—liver cancer	7.04e-06	0.000112	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CA—liver cancer	6.47e-06	0.000103	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—liver cancer	6.26e-06	0.0001	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HRAS—liver cancer	5.99e-06	9.56e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6—liver cancer	5.73e-06	9.15e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT1—liver cancer	5.29e-06	8.44e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CA—liver cancer	4.51e-06	7.21e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKT1—liver cancer	3.69e-06	5.89e-05	CbGpPWpGaD
